avrg: SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SOX9
|
ENSG00000125398.5 | SRY-box transcription factor 9 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SOX9 | hg19_v2_chr17_+_70117153_70117174 | 0.59 | 5.7e-03 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 12.4 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
1.8 | 7.1 | GO:0051710 | cytolysis by symbiont of host cells(GO:0001897) regulation of cytolysis in other organism(GO:0051710) |
1.4 | 8.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.8 | 4.7 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.8 | 2.3 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.7 | 4.9 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.7 | 2.0 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.7 | 3.3 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.6 | 3.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.6 | 2.4 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.6 | 1.8 | GO:0008057 | eye pigment granule organization(GO:0008057) |
0.6 | 1.7 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.5 | 2.0 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.5 | 11.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.4 | 6.3 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.4 | 15.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 1.3 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.4 | 2.2 | GO:0043553 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.4 | 1.3 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
0.4 | 1.3 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.4 | 3.0 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.4 | 1.8 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.3 | 2.4 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.3 | 1.4 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 2.1 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.3 | 2.7 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.3 | 1.0 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.3 | 5.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 0.9 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.3 | 3.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 0.9 | GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.3 | 0.9 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.3 | 0.9 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
0.3 | 2.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 0.8 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.3 | 3.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 2.5 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.2 | 1.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 1.2 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.2 | 2.4 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.2 | 4.6 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.2 | 0.8 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.2 | 3.5 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 1.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 1.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 1.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 2.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 0.5 | GO:1900222 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 4.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 1.4 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.2 | 1.9 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 2.0 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 3.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 0.5 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.2 | 1.0 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 3.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 1.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.2 | 0.5 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
0.2 | 3.8 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 1.5 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
0.1 | 2.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.9 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.1 | 0.4 | GO:0035283 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.6 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.1 | 1.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 1.1 | GO:0060992 | response to fungicide(GO:0060992) histone H3-K27 demethylation(GO:0071557) |
0.1 | 2.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.4 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.1 | 2.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 1.9 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 1.4 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 1.0 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.1 | 1.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.7 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.1 | 1.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 1.2 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.1 | 0.6 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.1 | 0.2 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.1 | 1.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 1.7 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.3 | GO:0032904 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.1 | 3.6 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 5.0 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 0.4 | GO:0032072 | plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) |
0.1 | 3.6 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.9 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 0.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.7 | GO:0035093 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.8 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.1 | 0.6 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 1.0 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 0.8 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 2.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.7 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 1.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.6 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.1 | 0.8 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.3 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.1 | 0.2 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.1 | 1.9 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 0.4 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.1 | 1.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.9 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.1 | 3.4 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.1 | 0.2 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.1 | 1.1 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 2.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 1.1 | GO:0098609 | cell-cell adhesion(GO:0098609) |
0.1 | 3.5 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.7 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.1 | 2.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 1.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 1.7 | GO:0030336 | negative regulation of cell migration(GO:0030336) |
0.1 | 0.4 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.5 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 2.2 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 0.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 1.0 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.9 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.5 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.1 | 0.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 1.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.3 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.0 | 1.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 1.0 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.8 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
0.0 | 0.8 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.0 | 0.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 2.9 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.0 | 1.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 1.4 | GO:0097320 | membrane tubulation(GO:0097320) |
0.0 | 0.6 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 1.0 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.5 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 2.3 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 1.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.4 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 3.8 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.6 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.0 | 0.6 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.1 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.0 | 0.3 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.0 | 0.6 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.0 | 0.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 2.6 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 0.3 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 1.4 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.6 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 5.3 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.0 | 0.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 3.3 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.4 | GO:0007411 | axon guidance(GO:0007411) |
0.0 | 0.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.0 | 0.1 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.0 | 0.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 1.1 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 2.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.7 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.4 | GO:0009214 | cAMP catabolic process(GO:0006198) cyclic nucleotide catabolic process(GO:0009214) |
0.0 | 1.1 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 1.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 3.2 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.8 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.4 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.0 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.0 | 0.3 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.2 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.0 | 0.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 2.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.2 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.0 | 2.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 1.9 | GO:0048678 | response to axon injury(GO:0048678) |
0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 1.6 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.4 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.0 | 1.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.6 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 1.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.6 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.7 | GO:0042278 | purine nucleoside metabolic process(GO:0042278) |
0.0 | 0.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.2 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.0 | 0.4 | GO:0070193 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.0 | 0.8 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.0 | 0.5 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.8 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 1.1 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.2 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.0 | 1.1 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.6 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.0 | 0.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.0 | 0.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 1.0 | GO:1905037 | autophagosome organization(GO:1905037) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 3.0 | GO:0031213 | RSF complex(GO:0031213) |
0.7 | 2.2 | GO:1990032 | parallel fiber(GO:1990032) |
0.6 | 1.8 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.5 | 16.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 3.5 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 2.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 0.8 | GO:0036457 | keratohyalin granule(GO:0036457) |
0.2 | 2.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.9 | GO:0060187 | cell pole(GO:0060187) |
0.2 | 5.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 0.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 5.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 5.0 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.2 | 1.5 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 15.4 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 4.9 | GO:0097386 | glial cell projection(GO:0097386) |
0.2 | 2.5 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 4.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 1.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 2.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 2.0 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 1.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.4 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 1.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 1.5 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 2.4 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 1.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 2.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 1.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 1.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.5 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.1 | 0.7 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 0.9 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.1 | 5.7 | GO:0002102 | podosome(GO:0002102) |
0.1 | 2.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 3.8 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 1.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 3.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 2.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 1.7 | GO:1990752 | microtubule end(GO:1990752) |
0.1 | 1.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 6.9 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 1.7 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 4.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.6 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.9 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 1.9 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.0 | 11.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.5 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 5.7 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.7 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.8 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.4 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 2.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 1.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 1.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 4.7 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 1.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 1.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 1.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 16.4 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.3 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.5 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.0 | 2.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.4 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.1 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.0 | 0.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.8 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.3 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 2.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.9 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 6.0 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 6.5 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 6.3 | GO:0055100 | adiponectin binding(GO:0055100) |
1.0 | 6.9 | GO:1990254 | keratin filament binding(GO:1990254) |
0.8 | 4.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.8 | 12.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.7 | 3.6 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.6 | 2.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.6 | 1.8 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.5 | 2.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 2.3 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.4 | 2.7 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.3 | 1.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.3 | 2.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.3 | 4.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 0.8 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.3 | 1.9 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 2.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 2.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 4.6 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 3.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 1.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.2 | 2.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 2.0 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 0.5 | GO:0001003 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.2 | 3.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.6 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.1 | 0.7 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.1 | 1.7 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.4 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
0.1 | 0.6 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
0.1 | 1.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.4 | GO:0061599 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
0.1 | 0.5 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 1.4 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 3.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.4 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.1 | 1.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 2.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 1.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 1.0 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.5 | GO:0010736 | serum response element binding(GO:0010736) |
0.1 | 2.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 2.8 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 1.1 | GO:0035005 | lipid kinase activity(GO:0001727) 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.5 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 2.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 1.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 1.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 1.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 13.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.8 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 2.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 4.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 2.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 3.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.3 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.1 | 0.6 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 1.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 1.9 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 1.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 2.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 1.8 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.8 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 5.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 1.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 2.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 5.0 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 1.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.7 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.1 | 1.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 1.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.8 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 3.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.4 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.1 | 2.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 2.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.3 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 0.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 10.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 1.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 3.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 6.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 1.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 3.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 1.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.5 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 1.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 1.0 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 1.0 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.7 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 3.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 1.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.3 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 2.2 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 1.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 1.0 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.6 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 2.1 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 3.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 1.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 2.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 1.0 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.0 | 0.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 1.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 1.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 1.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 1.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 2.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 1.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 1.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 1.4 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 2.2 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 1.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 1.5 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 1.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 1.6 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 1.8 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 17.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 20.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 9.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 6.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 4.0 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 8.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 5.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 5.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 1.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 2.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 2.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 1.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 2.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 3.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 2.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 3.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 1.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 2.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 2.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 1.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 1.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 2.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 1.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.1 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 3.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.7 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.2 | 17.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 4.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 6.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 3.5 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 1.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 2.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 0.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 2.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 2.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 2.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 5.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 2.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 1.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 2.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 1.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 1.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 2.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 1.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 1.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 3.0 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 2.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 2.1 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.0 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.0 | 0.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |